Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3049233	u-orgah	— (—)	109	125	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of psychological development

9.31

27.42

1.0

1.2

—

Epilepsy

6.88

20.24

1.3

1.1

—

Mental retardation, excluding more controls

27.18

18.40

1.2

1.4

—

Any mental disorder

8.35

16.11

1.0

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

4.96

15.01

1.2

1.1

—

Motor disorders, excluding more controls

22.57

14.68

1.0

1.4

—

Speech and linguistic disorders, excluding more controls

16.67

14.57

1.0

1.3

—

Delayed milestone in childhood

5.78

14.57

1.2

—

Care involving use of rehabilitation procedures

5.07

14.43

1.2

—

Procreative management

5.21

14.40

1.1

1.2

—

Mental retardation, wide definition

5.97

14.17

1.2

—

Mental retardation

5.97

14.16

1.2

—

Psychiatric diseases

7.95

14.07

1.0

1.2

—

Speech and linguistic disorders

5.17

14.06

1.1

1.2

—

Persons encountering health services for specific procedures and health care

4.09

13.40

1.1

—

Mixed specific developmental disorders

10.76

13.13

1.1

1.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

4.83

12.80

1.2

—

Headache

6.80

12.79

1.0

1.2

—

Specific developmental disorder of motor function

12.38

11.97

1.0

1.4

—

Motor disorders

5.80

11.43

1.0

1.2

—

Hyperkinetic disorders, excluding more controls

13.66

11.28

1.1

1.3

—

Lack of expected normal physiological development

10.40

10.84

1.1

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.21

10.44

1.1

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

5.41

10.38

1.2

—

Other problems related to primary support group, including family circumstances

4.67

10.05

1.2

—

Nausea and vomiting

5.00

9.93

1.1

—

Intestinal infectious diseases

3.61

9.86

1.1

1.2

—

Convulsions, not elsewhere classified

8.94

9.41

1.3

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.17

9.18

1.2

—

Neurological diseases

3.66

9.00

1.2

1.1

—

Diseases of the myoneural junction and muscle

18.61

8.92

1.2

1.1

—

Specific development disorders of speech and language

8.01

8.81

1.0

1.3

—

Focal epilepsy

6.46

8.15

1.4

1.1

—

Focal epilepsy, strict definition

6.79

8.04

1.4

1.1

—

Disorders of refraction and accommodation

3.99

8.00

1.0

1.1

—

Strabismus

3.92

7.83

1.4

1.1

—

Metabolic disorders

3.65

7.72

1.3

1.1

—

Other strabismus

4.16

7.67

1.4

1.1

—

Endocrine, nutritional and metabolic diseases

3.33

7.09

1.2

1.1

—

Hyperkinetic disorders

3.73

6.95

1.1

1.2

—

Other disorders starting during childhood or adolecense, excluding more controls

9.58

6.81

1.1

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.28

6.73

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

8.31

6.66

1.2

1.0

—

Medical observation and evaluation for suspected diseases and conditions

8.18

6.58

1.1

1.0

—

Pain, not elsewhere classified

12.23

6.57

1.3

1.1

—

Other disorders of glucose regulation and pancreatic internal secretion

8.69

6.54

1.2

1.0

—

General symptoms and signs

4.08

6.51

1.0

1.2

—

Specific development disorders of scholastic skills

9.84

6.44

1.2

1.4

—

Viral and other specified intestinal infections, including avohilmo

3.63

6.38

1.1

1.2

—

Anxiety disorders, excluding more controls

7.37

6.22

1.1

1.3

—

Wide developmental disorders, excluding more controls

10.80

6.20

1.1

1.4

—

Codes for special purposes

3.80

6.16

1.3

1.1

—

Episodal and paroxysmal disorders

2.83

6.10

1.2

1.1

—

Disorders of other endocrine glands

3.19

6.08

1.2

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

11.77

5.85

1.2

1.0

—

Persons encountering health services in circumstances related to reproduction

3.06

5.82

1.2

—

Viral and other specified intestinal infections

3.77

5.75

1.1

1.2

—

Malaise and fatigue

5.90

5.67

1.2

1.3

—

Disturbances of skin sensation

12.86

5.57

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.48

5.53

1.1

—

Astigmatism

5.85

5.51

1.2

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

5.84

5.51

1.4

1.2

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.72

5.42

1.1

1.0

—

Disturbance of activity and attention

3.61

5.42

1.1

1.2

—

Diseases of the eye and adnexa

3.25

5.35

1.2

1.0

—

Examination and observation for other reasons

7.33

5.28

1.0

—

Cardiomyopathy

11.25

5.28

1.1

1.0

—

Fever of other and unknown origin

5.20

5.27

1.1

1.2

—

Provisional assignment of new diseases of uncertain etiology

3.51

5.23

1.2

1.1

—

Visual disturbances and blindness

3.33

5.14

1.2

1.1

—

Hypoglycaemia, other or unspecified

7.36

5.14

1.3

1.0

—

Implicit Sepsis

3.27

5.13

1.2

—

Other functional intestinal disorders

2.94

5.03

1.3

1.1

—

Complications of surgical and medical care, not elsewhere classified

3.53

4.99

1.1

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

3.37

4.81

1.1

1.0

—

GASTRO-related operations

2.92

4.76

1.2

1.1

—

Any gastric operation

2.92

4.76

1.2

1.1

—

Other and unspecified mental retardation

4.45

4.72

1.4

1.2

—

Benzodiazepine use

3.20

4.62

1.3

1.2

—

Other metabolic disorders

14.01

4.57

2.0

1.0

—

Congenital malformations of the nervous system

8.25

4.57

1.2

1.5

—

Influenza and pneumonia

2.47

4.54

1.2

1.1

—

Disorders of speech understanding and production

4.45

4.47

1.0

1.3

—

Other reaction to severe stress, and adjustment disorders

6.66

4.46

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

3.03

4.41

1.1

1.2

—

Implicit Sepsis, including avohilmo

2.88

4.40

1.2

—

Complications of procedures, not elsewhere classified

4.51

4.39

1.1

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.49

4.36

1.1

1.2

—

Complications of medical and surgical care

4.08

4.35

1.1

—

Cerebral palsy and other paralytic syndromes

6.26

4.29

1.5

1.0

—

Nystagmus and other irregular eye movements

11.79

4.28

1.4

1.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

8.63

4.19

1.3

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2.68

4.18

1.2

1.1

—

Other disorders of eye and adnexa

5.89

4.12

1.3

1.2

—

Neurotic, stress-related and somatoform disorders

3.16

4.10

1.1

—

Anxiety disorders

3.15

4.07

1.1

—

3.34

3.96

1.4

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.34

3.96

1.4

1.0

—

Covid-19 confirmed case

4.28

3.80

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.64

3.78

1.2

1.1

—

Gastro-oesophageal reflux disease

3.28

3.78

1.3

1.2

—

Visual disturbances

3.18

3.77

1.2

—

12.01

3.76

1.2

1.0

—

Myalgia

12.00

3.76

1.0

1.8

—

Any death

6.29

3.67

1.2

1.0

—

Keratitis

6.67

3.67

1.3

1.0

—

Implicit viral Sepsis

5.63

3.65

1.2

1.3

—

Viral Sepsis

5.63

3.65

1.2

1.3

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.13

3.64

1.1

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.40

3.54

1.1

1.2

—

Mood disorders, excluding more controls

5.34

3.50

1.1

1.0

—

Heterophoria

6.16

3.50

1.1

1.3

—

Systemic connective tissue disorders

10.00

3.49

1.0

1.2

—

Visual impairment including blindness (binocular or monocular)

7.01

3.36

1.1

—

Other neurological diseases

3.60

3.35

1.2

1.1

—

Hypermetropia

4.35

3.30

1.2

—

Disorders of conjunctiva

2.31

3.29

1.4

1.1

—

Other congenital malformations of brain

8.79

3.28

1.3

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

5.06

3.26

1.0

—

Conjunctivitis

2.33

3.23

1.4

1.1

—

Other arrhythmias

3.73

3.22

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

2.32

3.22

1.3

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.61

3.18

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

2.51

3.17

1.2

1.1

—

All pneumoniae

2.16

3.09

1.2

1.1

—

Other and unspecified tonsillitis

3.27

3.08

1.1

1.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2.54

3.06

1.3

1.0

—

Dysphagia

7.50

3.05

1.7

1.0

—

Pervasive developmental disorders excl. Autism + Asperger

4.99

3.02

1.0

1.4

—

Conjunctivitis (acute, non atopic)

2.67

3.02

1.3

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2.21

3.00

1.0

1.2

—

Moderate mental retardation

10.16

2.99

1.4

1.0

—

Corneal ulcer

10.00

2.98

1.0

—

Disorders of sclera, cornea, iris and ciliary body

3.85

2.97

1.2

1.0

—

Mild mental retardation

4.73

2.92

1.0

1.1

—

All influenza (not pneumonia)

4.71

2.91

1.1

—

Open bite

3.71

2.88

1.4

1.2

—

Abnormalities of gait and mobility

5.39

2.87

1.1

1.3

—

Use of hypnotics and sedatives

2.38

2.85

1.4

1.1

—

Abnormalities of breathing

2.19

2.75

1.1

1.2

—

Haemolytic anaemias

8.36

2.75

1.0

1.8

—

Open wound of ankle and foot

8.34

2.75

1.0

1.2

—

Persons encountering health services for examination and investigation

4.51

2.74

1.1

1.0

—

Cerebral palsy

5.04

2.73

1.6

1.0

—

Other disorders starting during childhood or adolescence

2.52

2.72

1.3

1.2

—

Oedema, not elsewhere classified

8.14

2.70

1.2

1.7

—

All dysplastic lesions of the cervix uteri, vagina or vulva

8.13

2.70

1.2

1.0

—

Oral corticosteroids

2.93

2.70

1.2

1.1

—

Symptoms and signs concerning food and fluid intake

5.99

2.69

1.3

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

6.66

2.65

1.2

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

2.41

2.64

1.3

1.0

—

Ischaemic Stroke, excluding all haemorrhages

6.31

2.62

1.0

—

Pneumonia, organism unspecified

2.12

2.57

1.3

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.05

2.55

1.3

1.1

—

Cerebrovascular diseases

4.27

2.55

1.0

1.4

—

Wide developmental disorders

3.06

2.55

1.1

1.3

—

Dilated cardiomyopathy

7.15

2.55

1.2

1.0

—

Cardiomyopathies, Primary/intrinsic

7.15

2.55

1.2

1.0

—

Cardiomyopathy (excluding other)

7.15

2.55

1.2

1.0

—

Concussion

2.58

2.54

1.1

—

Symptoms and signs involving speech and voice

5.46

2.54

1.0

1.1

—

Dependence on enabling machines and devices, not elsewhere classified

5.49

2.54

1.2

1.5

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.74

2.53

1.4

1.1

—

Gastrointestinal diseases

2.28

2.53

1.3

1.1

—

Other anxiety disorders

3.27

2.49

1.1

—

Acute upper respiratory infections

2.46

2.48

1.1

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.97

2.48

1.1

1.2

—

Implicit viral Sepsis, including avohilmo

3.45

2.47

1.2

—

Other headache syndromes

4.36

2.46

1.0

1.1

—

Any reimbursement code in KELA

2.43

2.46

1.1

—

Acute pharyngitis

3.43

2.45

1.1

1.0

—

STROKE

4.71

2.44

1.0

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.40

2.39

1.1

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.34

2.38

1.1

1.0

—

Implicit bacterial Sepsis

4.29

2.38

1.1

1.4

—

Emotional disorders and disorders of social functioning with onset specific to childhood

3.07

2.37

1.2

1.3

—

Nonischemic cardiomyopathy

6.25

2.37

1.2

1.1

—

Transplanted organ and tissue status

3.64

2.36

1.0

1.3

—

All influenza

3.03

2.35

1.1

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6.02

2.34

1.2

1.0

—

Infections, IBD-co-morbidities

5.27

2.34

1.0

—

Fitting and adjustment of other devices

6.29

2.33

1.2

1.0

—

Asthma (mode)

3.28

2.31

1.1

1.0

—

Dental caries

2.81

2.30

1.1

1.2

—

Migraine without aura

3.22

2.30

1.1

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

1.96

2.29

1.3

1.1

—

Other diseases of the respiratory system

4.62

2.27

1.2

1.1

—

Other respiratory disorders and diseases

4.62

2.27

1.2

1.1

—

Allergic conjunctivitis

2.56

2.26

1.4

1.1

—

Asthma

3.22

2.26

1.1

1.0

—

Other medical care

3.53

2.24

1.3

1.1

—

Birth asphyxia

5.66

2.22

1.6

1.4

—

Cerebrovascular diseases (FINNGEN)

4.09

2.22

1.0

1.3

—

Intermittent heterotropia

3.10

2.22

1.3

1.2

—

Immunodeficiencies

5.57

2.21

1.0

1.6

—

Superficial injury of abdomen, lower back and pelvis

5.56

2.21

1.2

1.1

—

Ulcerative colitis

5.56

2.21

1.2

1.0

—

Caries of dentine

3.10

2.21

1.0

1.3

—

Cardiac arrhythmias

2.42

2.17

1.0

1.1

—

Persons encountering health services in other circumstances, wide

1.96

2.17

1.1

—

Inflammatory diseases of female pelvic organs

3.99

2.17

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.94

2.16

1.0

1.2

—

Acute sinusitis

3.30

2.13

1.1

1.0

—

All anxiety disorders

2.67

2.12

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.21

2.09

1.4

1.1

—

Implicit bacterial Sepsis, including avohilmo

3.64

2.07

1.1

1.3

—

Autism spe

5.02

2.07

1.2

—

Viral pneumonia

5.00

2.07

1.0

—

5-aminosalicylic acid

5.00

2.07

1.2

1.1

—

Obesity related asthma

5.00

2.07

1.0

—

Schizophrenia or delusion

5.00

2.07

1.0

—

Schizophrenia, schizotypal and delusional disorders

5.00

2.07

1.0

—

Asthma (only as main-diagnosis)

3.14

2.06

1.1

1.0

—

Hypothyroidism and >3 levothyroxin purchases

3.92

2.06

1.0

1.2

—

Hypothyroidism, levothyroxine purchases

3.92

2.06

1.0

1.2

—

Stroke, excluding SAH

4.33

2.06

1.0

—

Nerve, nerve root and plexus disorders

2.86

2.05

1.1

1.0

—

Stroke, including SAH

4.30

2.05

1.0

—

Asthma (only as main-diagnosis), excluding more controls

3.11

2.04

1.1

1.0

—

Dialysis, with operation codes

4.00

2.04

1.0

1.3

—

Migraine without aura and triptan purchases

4.00

2.04

1.2

1.1

—

Nutritional anaemias

2.86

2.02

1.0

1.2

—

Migraine

2.46

2.01

1.1

—

Other and unspecified iron deficiency

3.07

2.00

1.0

1.2

—

Abdominal and pelvic pain

1.99

1.98

1.1

—

Bronchitis

2.18

1.97

1.1

1.0

—

Otalgia

3.34

1.96

1.0

1.1

—

Bacterial Sepsis

3.01

1.91

1.1

1.2

—

Asthma, unspecified (mode)

3.93

1.91

1.2

1.0

—

Hypothyroidism (congenital or acquired)

3.56

1.90

1.0

1.2

—

Asthma, unspecified (mode), excluding more controls

3.90

1.90

1.2

1.0

—

Other symptoms and signs involving cognitive functions and awareness

4.43

1.87

1.0

1.1

—

Sleep apnoea, including avohilmo

2.56

1.87

1.0

1.1

—

Other congenital malformations, including avohilmo

2.31

1.87

1.1

1.2

—

Mouth breathing

2.15

1.87

1.1

1.2

—

Asthma, excluding more controls

2.89

1.86

1.1

1.0

—

Irregular menses

3.28

1.86

1.1

1.0

—

Anaemias

2.52

1.85

1.1

1.3

—

Other congenital malformations

2.39

1.84

1.1

1.2

—

Other diseases of blood and blood-forming organs, wide

3.53

1.83

1.0

1.1

—

Inflammatory bowel disease

3.53

1.83

1.2

1.1

—

Certain conditions originating in the perinatal period

2.15

1.82

1.4

1.1

—

Cholelithiasis

3.72

1.81

1.0

1.1

—

Diseases of the respiratory system

3.08

1.81

1.1

1.0

—

Excessive, frequent and irregular menstruation

3.40

1.81

1.0

—

Non-allergic asthma (mode), excluding more controls

4.13

1.81

1.2

1.0

—

Non-allergic asthma (mode)

4.13

1.81

1.2

1.0

—

L04AA Selective immunosuppressants

3.05

1.79

1.0

1.2

—

Bacterial pneumonia, not elsewhere classified

3.07

1.78

1.1

—

Emotional disorders starting during childhood or adolescence

2.55

1.77

1.2

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.85

1.77

1.0

1.1

—

Acute tubulo-interstitial nephritis

2.19

1.77

1.4

1.1

—

Abnormal serum enzyme levels

4.02

1.76

1.4

1.0

—

Iron deficiency anaemia

2.71

1.74

1.0

1.2

—

Certain disorders involving the immune mechanism

3.33

1.74

1.0

1.3

—

Intracranial trauma

2.15

1.73

1.1

—

Other eating disorders

3.85

1.71

1.4

1.1

—

Bacterial pneumoniae

2.93

1.70

1.1

1.0

—

Heart failure, not strict

2.38

1.70

1.0

1.2

—

Congenital malformations of the circulatory system

2.06

1.69

1.2

—

Cholecystectomy

3.86

1.68

1.0

1.1

—

Dyspnoea

2.04

1.68

1.1

1.2

—

Explicit Sepsis

2.53

1.67

1.1

—

Amblyopia ex anopsia

2.81

1.65

1.4

1.2

—

Cholelithiasis, broad definition with cholecystitis

3.33

1.64

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2.03

1.63

1.3

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.88

1.63

1.1

1.2

—

Exclusions for E4_PCOS_BROAD

2.24

1.63

1.0

1.2

—

Explicit Sepsis, including avohilmo

2.38

1.61

1.1

—

Nonsuppurative otitis media

2.17

1.61

1.2

1.1

—

Other endocrine disorders

2.08

1.60

1.5

1.2

—

Nonsuppurative otitis media, including avohilmo

2.16

1.59

1.4

1.0

—

COPD differential diagnosis

2.82

1.58

1.1

1.0

—

ILD differential diagnosis

2.82

1.58

1.1

1.0

—

Other pulmonary diagnosis

2.82

1.58

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

2.82

1.58

1.1

1.0

—

Type 2 diabetes

2.89

1.58

1.1

1.0

—

Hypopituitarism

2.69

1.58

1.0

1.2

—

Hypothyroidism, other/unspecified

2.19

1.55

1.1

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3.53

1.54

1.2

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.18

1.54

1.1

1.0

—

Type 2 diabetes, strict (exclude DM1)

3.17

1.54

1.2

1.0

—

Type 2 diabetes, definitions combined

3.17

1.54

1.2

1.0

—

Cough

2.11

1.54

1.2

—

Constipation

1.78

1.53

1.4

1.1

—

Noninfective enteritis and colitis

2.03

1.53

1.1

1.2

—

Abnormal findings on examination of blood, without diagnosis

2.64

1.52

1.3

1.0

—

Short stature, not elsewhere classified

2.11

1.52

1.2

—

Other postsurgical states

3.34

1.52

1.2

1.4

—

Mycoses

3.33

1.52

1.0

1.1

—

Eating disorders

3.33

1.52

1.4

1.1

—

Eating disorder

3.33

1.52

1.4

1.1

—

Artificial joint operation, meniscal resection

3.55

1.50

1.0

—

Other diseases of pleura

2.90

1.50

1.2

1.3

—

Inflammatory bowel disease treatment related agents

1.76

1.50

1.1

1.2

—

Sleep apnoea

2.33

1.47

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

1.87

1.46

1.1

—

Other chromosome abnormalities, not elsewhere classified

3.19

1.45

1.4

—

Other diseases of intestines

1.67

1.44

1.3

1.1

—

Other specified congenital malformation syndromes affecting multiple systems

3.14

1.44

1.0

1.1

—

Myopia

3.13

1.44

1.2

1.1

—

Pain in limb

1.74

1.42

1.1

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

2.89

1.41

1.2

1.0

—

Otitis media, unspecified

2.19

1.40

1.2

1.1

—

Other and unspecified anaemias

2.68

1.40

1.2

—

Other anaemias

2.67

1.39

1.2

—

Bacterial pneumonia (organism specified)

2.44

1.39

1.1

1.2

—

Abnormalities of heart beat

3.03

1.39

1.0

1.3

—

L04AD Calcineurin inhibitors

2.42

1.39

1.0

1.2

—

Crowding of teeth, including avohilmo

1.96

1.37

1.0

1.3

—

Nephropathy related operations

2.94

1.36

1.0

1.3

—

Candidiasis, including avohilmo

2.94

1.36

1.0

1.1

—

Exclusion endpoint for clefts

2.95

1.36

1.0

1.1

—

Hyperkinetic disorders (excl. ADHD)

2.91

1.34

1.0

1.4

—

Septicaemia

2.16

1.34

1.1

—

Other and unspecified effects of external causes

2.13

1.33

1.1

1.2

—

Insomnia

2.17

1.30

1.0

1.1

—

Other disorders originating in the perinatal period

2.38

1.30

2.0

1.1

—

Autoimmune diseases related-to ILD

2.04

1.29

1.1

—

Depression or dysthymia

3.03

1.28

1.2

1.0

—

Other soft tissue disorders, not elsewhere classified

1.65

1.28

1.1

1.2

—

Dizziness and giddiness

2.30

1.26

1.0

1.1

—

Other septicaemia

2.29

1.26

1.1

—

Anxiety (asthma-related co-morbidities)

2.07

1.26

1.1

—

Other septicaemia, including avohilmo

2.27

1.26

1.1

—

Temporomandibular joint disorders, including avohilmo

2.42

1.25

1.0

—

Disorders of gallbladder, biliary tract and pancreas

2.14

1.24

1.0

1.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

2.40

1.24

1.2

—

Parasetamol

2.20

1.24

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.81

1.24

1.2

1.1

—

ILD medications: immunosuppressive drugs

1.84

1.18

1.2

—

Tonsillectomy and adenotomy

1.65

1.18

1.2

—

Exposure to other specified factors

1.72

1.17

1.1

—

Pediculosis, acariasis and other infestations, including avohilmo

0.00

1.16

0.0

1.2

—

Other disorders of urethra and urinary system

2.05

1.15

1.1

1.2

—

Aplastic and other anaemias

2.37

1.13

1.1

1.2

—

Polycystic ovarian syndrome, consortium definition

2.36

1.12

1.1

1.0

—

Disorders of skin appendages

1.99

1.11

1.0

1.1

—

Acute suppurative otitis media

1.90

1.11

1.1

—

Anomalies of dental arch relationship, including avohilmo

1.84

1.10

1.1

1.2

—

Chromosomal abnormalities, not elsewhere classified

2.19

1.08

1.3

—

COPD/asthma/ILD related infections

1.97

1.07

1.1

1.0

—

COPD/asthma related infections

1.97

1.07

1.1

1.0

—

Other heart diseases, wide

1.59

1.07

1.1

1.2

—

Other antidepressants

2.04

1.07

1.1

1.0

—

Intracranial injury

1.75

1.05

1.2

1.1

—

Pain in throat and chest

1.91

1.04

1.0

1.1

—

Chronic diseases of tonsils and adenoids

1.62

1.04

1.2

—

Impetigo

2.28

1.03

1.0

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

2.27

1.03

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.59

1.01

1.4

1.1

—

Conjunctivitis (acute, non atopic), including avohilmo

1.66

1.01

1.1

—

Other noninfective gastroenteritis and colitis

1.89

1.01

1.1

1.2

—

Cardiovascular diseases

1.54

1.00

1.0

1.2

—

Other nutritional deficiencies

1.87

0.99

1.0

1.2

—

Certain infectious and parasitic diseases

1.64

0.98

1.3

1.1

—

Other viral diseases, including avohilmo

1.67

0.98

1.1

1.2

—

Depression

1.84

0.97

1.1

1.0

—

Scabies, including avohilmo

0.00

0.96

0.0

1.2

—

Other inflammation of eyelid, including avohilmo

1.76

0.94

1.0

1.2

—

Other disorders of skin and subcutaneous tissue

1.90

0.94

1.1

1.2

—

ILD medications

1.54

0.93

1.1

1.2

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

2.22

0.93

1.2

—

Childhood allergy (age < 16)

1.65

0.92

1.3

1.1

—

Suppurative and unspecified otitis media

1.77

0.92

1.1

—

Congenital malformations of heart and great arteries

1.71

0.91

1.2

—

Paroxysmal tachycardia

2.08

0.89

1.0

1.1

—

Disorders of the thyroid gland

1.78

0.89

1.1

1.0

—

Genitourinary diseases

1.54

0.88

1.3

1.2

—

Neurological diseases, wide definition

1.78

0.84

1.1

—

All kidney diseases

1.54

0.84

1.3

1.1

—

Triptan medication for migraine, min. 3 purchases

1.95

0.84

1.2

1.0

—

Symptoms and signs involving the urinary system

1.73

0.83

1.0

1.2

—

Pain in joint

1.75

0.82

1.1

1.2

—

Diseases of the ear and mastoid process

1.55

0.82

1.1

—

Other and unspecified urticaria

1.88

0.81

1.0

1.2

—

Congenital malformations of genital organs

1.86

0.81

1.0

1.3

—

Mood [affective] disorders

1.72

0.80

1.1

1.0

—

Mood disorders

1.71

0.79

1.1

1.0

—

1.69

0.79

1.1

1.0

—

Renal tubulo-interstitial diseases

1.58

0.78

1.4

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

1.59

0.78

1.1

1.2

—

Diseases of middle ear and mastoid

1.63

0.77

1.1

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.76

0.0

1.2

—

Cystitis

1.61

0.76

1.0

1.2

—

Persons with potential health hazards related to communicable diseases

1.57

0.75

1.1

1.2

—

Azathioprine

2.08

0.74

1.0

1.3

—

Other disorders of penis

2.08

0.74

1.0

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.05

0.74

1.2

1.0

—

Respiratory distress of newborn

1.65

0.74

1.1

1.2

—

Caries of dentine, including avohilmo

0.61

0.73

1.0

1.2

—

ILD medications: azathioprine

2.00

0.72

1.0

1.2

—

Viral warts, including avohilmo

1.80

0.72

1.3

1.1

—

Acute bronchitis

1.58

0.71

1.2

—

Renal failure

1.94

0.70

1.0

1.3

—

Other viral diseases

1.57

0.70

1.1

1.2

—

Codeine

1.93

0.69

1.2

1.0

—

Noninflammatory disorders of female genital tract

1.93

0.69

1.0

1.2

—

Persons encountering health services in other circumstances

1.69

0.69

1.1

1.2

—

Gingivitis and periodontal diseases

0.62

0.67

1.1

1.2

—

Other acute lower respiratory infections

1.54

0.65

1.1

1.2

—

Sleep disorders

1.64

0.64

1.1

—

Neoplasms

0.63

1.1

1.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.67

0.61

1.0

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

1.59

0.61

1.6

1.1

—

Sleep disorders (combined)

1.49

0.61

1.1

1.2

—

Contact with and exposure to communicable diseases

1.54

0.61

1.1

1.2

—

All chronic kidney diseases

1.59

0.60

1.5

1.1

—

Opioids

1.82

0.60

1.2

1.0

—

Codeine or tramadol medication

1.81

0.60

1.2

1.0

—

Antihypertensive medication - note that there are other indications

1.44

0.60

1.0

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.59

0.0

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

1.42

0.59

1.2

—

Malignant neoplasm, including Hilmo

0.56

0.58

1.2

—

Malignant neoplasm, wide definition

0.56

0.58

1.2

—

Dermatitis and eczema

1.37

0.57

1.3

1.1

—

Mycoses, including avohilmo

1.52

0.56

1.1

—

Obesity

1.61

0.55

1.0

1.1

—

Obesity and other hyperalimentation

1.61

0.55

1.0

1.1

—

Other diseases of urinary system

1.43

0.55

1.1

1.2

—

1.47

0.55

1.1

1.2

—

Atopic dermatitis, strict definition

1.47

0.54

1.5

1.1

—

Atrial septal defect, secundum type

1.58

0.54

1.3

—

Certain infectious and parasitic diseases, including avohilmo

1.50

0.54

1.1

1.0

—

Other viral diseases, not elsewhere classified

1.50

0.54

1.1

1.2

—

Injuries to the ankle and foot

1.44

0.53

1.1

1.2

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

1.47

0.53

1.1

1.2

—

Disorders of eyelid, lacrimal system and orbit

1.53

0.51

1.1

1.2

—

Diseases of the skin and subcutaneous tissue

1.38

0.51

1.0

1.1

—

Other and unspecified dermatitis

1.46

0.50

1.0

1.1

—

Other viral diseases, not elsewhere classified, including avohilmo

1.46

0.49

1.1

1.2

—

Congenital malformations of cardiac septa

1.49

0.49

1.2

—

First line medication for Crohn's disease

1.34

0.49

1.1

1.2

—

Tooth eruption problems

1.50

0.48

1.4

1.2

—

Malignant neoplasm

0.60

0.47

1.2

—

Asthma/COPD (KELA code 203)

1.34

0.44

1.1

—

Any event in cancer register

0.65

0.44

1.2

—

Diabetes medication

0.63

0.44

1.2

—

Chronic lower respiratory diseases

1.29

0.43

1.0

1.2

—

Pain (limb, back, neck, head abdominally)

1.38

0.43

1.1

1.2

—

Other bacterial diseases, including avohilmo

0.71

0.43

1.1

1.2

—

Used for control exclusion in common control thyroid runs

1.29

0.43

1.1

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.61

0.43

2.0

1.1

—

Obesity due to excess calories

1.61

0.43

1.0

1.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.61

0.43

1.0

1.3

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.45

0.42

1.3

1.2

—

Excessive earwax

1.39

0.42

1.4

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.00

0.41

0.0

1.1

—

Accidents

0.66

0.41

1.0

1.2

—

Superficial injury of wrist and hand

1.52

0.41

1.4

1.1

—

Juvenile arthritis (FINNGEN)

0.00

0.41

0.0

1.1

—

Unspecified mental disorder

0.00

0.41

0.0

1.1

—

Urticaria and erythema

1.36

0.41

1.0

1.2

—

Congenital malformations and deformations of the musculoskeletal system

1.35

0.40

1.1

1.2

—

Injuries to the wrist and hand

1.33

0.40

1.2

1.1

—

Asthma-related infections

1.36

0.39

1.1

1.2

—

Asthma, hospital admission 2, infections

1.36

0.39

1.1

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

1.41

0.39

1.0

—

Vasomotor and allergic rhinitis

1.35

0.38

1.0

1.2

—

Crossbite

1.34

0.38

1.0

1.2

—

Exposure to unspecified factor

1.28

0.37

1.1

1.2

—

Injury, poisoning and certain other consequences of external causes

0.63

0.37

1.0

1.2

—

Acute bronchiolitis

1.29

0.36

1.1

1.2

—

Open wound of head

1.28

0.36

1.1

—

Hypothyroidism, strict autoimmune

1.46

0.36

1.0

—

Atrial septal defect

1.46

0.36

1.3

1.2

—

Unspecified fall

1.38

0.36

1.0

1.2

—

Diseases of the digestive system

1.35

0.34

1.2

—

Atopic dermatitis

1.31

0.34

1.4

1.1

—

Diseases of male genital organs

1.35

0.32

1.0

1.2

—

Hard cardiovascular diseases

1.30

0.31

1.0

1.2

—

Urticaria

1.30

0.30

1.0

1.2

—

Other fall from one level to another

1.30

0.30

1.1

1.2

—

Atopic dermatitis, strict definition with reimbursement

1.33

0.30

1.5

1.1

—

Infections of the skin and subcutaneous tissue

1.30

0.29

1.0

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

1.23

0.28

1.1

1.2

—

Soft tissue disorders

1.22

0.28

1.2

—

Second line medication for Crohn's disease

1.29

0.28

1.1

1.2

—

Viral infections characterized by skin and mucous membrane lesions

1.25

0.27

1.9

1.1

—

Malignant neoplasm

0.67

0.27

1.2

—

Hernia

0.66

0.26

1.0

1.2

—

Injuries to the head

1.21

0.25

1.2

1.1

—

Adverse effects, not elsewhere classified

1.32

0.23

1.0

1.3

—

Effects of foreign body entering through natural orifice

1.28

0.23

1.0

1.2

—

Superficial injury of head

1.28

0.23

1.2

—

Caries of enamel

1.21

0.22

1.1

1.2

—

Delivery

0.00

0.22

0.0

1.2

—

Single spontaneous delivery

0.00

0.22

0.0

1.2

—

Delivery, wide proxy

0.00

0.22

0.0

1.2

—

Diabetic retinopathy, excluding more controls

0.00

0.22

0.0

1.1

—

Acne, including avohilmo

1.23

0.22

1.0

1.1

—

Other external causes of accidental injury

0.76

0.22

1.0

1.2

—

Maternal care for known or suspected abnormality of pelvic organs

0.00

0.22

0.0

1.1

—

Pregnancy, childbirth and the puerperium

0.00

0.22

0.0

1.1

—

Valvular heart disease excluding rheumatic fever

1.19

0.21

1.0

1.2

—

Disorders of vitreous body and globe

0.00

0.21

0.0

1.0

—

Chronic periodontitis, complicated

0.00

0.21

0.0

1.0

—

Coarctation of the aorta

0.00

0.21

0.0

1.1

—

Type 1 diabetes

1.19

0.21

1.2

1.3

—

Varicella [chickenpox]

0.00

0.21

0.0

1.1

—

Pain associated with micturition

0.00

0.21

0.0

1.0

—

Kela-code for severe mental illness

0.00

0.21

0.0

1.0

—

Other disorders of veins

0.00

0.21

0.0

1.1

—

Asthma-related pneumonia

1.19

0.21

1.0

1.3

—

Asthma-related pneumonia or sepsis

1.19

0.21

1.0

1.3

—

Asthma, hospital admissions 3, pneumonia

1.19

0.21

1.0

1.3

—

Diseases of the musculoskeletal system and connective tissue

1.20

0.21

1.1

—

Varicose veins

0.00

0.21

0.0

1.0

—

Dermatophytosis, including avohilmo

1.17

0.21

1.0

1.1

—

Diabetic retinopathy

0.00

0.21

0.0

1.1

—

Poisoning by medicine

0.00

0.21

0.0

1.1

—

Poisoning by drugs, medicaments and biological substances

0.00

0.21

0.0

1.1

—

Other juvenile arthritis

0.00

0.20

0.0

1.4

—

Herpesviral [herpes simplex] infections, including avohilmo

0.00

0.20

0.0

1.1

—

Dermatitis

1.20

0.19

1.0

1.1

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.13

0.18

1.0

1.2

—

Hypertensive diseases (excluding secondary)

1.16

0.18

1.0

1.3

—

Other diseases of upper respiratory tract

1.17

0.18

1.1

1.2

—

L04AX Other immunosuppressants

1.15

0.17

1.1

1.2

—

0.76

0.17

1.0

1.2

—

Finngen Rheumatological endpoints

1.16

0.17

1.4

1.0

—

Dental caries, including avohilmo

0.83

0.16

1.1

1.2

—

Septal defects

1.14

0.16

1.3

1.2

—

Other specific joint derangements/joint disorders

1.22

0.16

1.1

—

Injuries to the elbow and forearm

1.15

0.15

1.1

—

External causes of morbidity and mortality

0.80

0.15

1.0

1.2

—

Fall on same level

0.87

0.15

1.2

1.1

—

Allergic rhinitis

1.12

0.15

1.0

1.2

—

Diseases of pulp and periapical tissues and dental caries

0.84

0.14

1.1

1.2

—

Diabetes, varying definitions

1.18

0.13

1.2

—

Diabetes mellitus

1.18

0.12

1.2

—

Other heart diseases

1.15

0.11

1.1

1.2

—

Other disorders of ear

1.14

0.10

1.0

1.2

—

Paracetamol or NSAID medication

1.10

0.10

1.2

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.12

0.10

1.0

—

Sub-endpoint used in defining T1D endpoints

1.14

0.10

1.2

1.3

—

Fracture of lower leg, including ankle

1.14

0.10

1.0

1.1

—

Other congenital malformations of the digestive system

1.08

0.09

1.0

1.3

—

Fracture of forearm

1.07

0.09

1.2

1.1

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.13

0.09

1.0

1.2

—

Striking against or struck by other objects

1.11

0.09

1.3

1.2

—

Personal history of other diseases and conditions

1.11

0.09

1.3

1.2

—

Triptan medication for migraine, single purchase ok

1.04

0.08

1.2

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.04

0.08

1.2

1.0

—

Dental pulpitis, including avohilmo

0.80

0.08

1.0

1.1

—

Dermatitis due to ingested food

0.82

0.08

1.2

1.1

—

Hypertensive diseases

1.07

0.08

1.0

1.3

—

Hypertension

1.07

0.08

1.0

1.3

—

Selective serotonin reuptake inhibitors

0.82

0.08

1.0

1.1

—

Other dorsopathies, not elsewhere classified

0.80

0.08

1.0

1.2

—

Bleeding

1.02

0.08

1.1

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.10

0.07

1.1

1.2

—

Autoimmune diseases excluding thyroid diseases

1.10

0.07

1.1

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

0.83

0.07

1.1

1.2

—

Major coronary heart disease event

1.06

0.07

1.0

1.2

—

Ischemic heart diseases

1.05

0.07

1.0

1.2

—

Asthma, hospital admissions , main diagnosis only

1.09

0.04

1.1

1.2

—

Injuries to the knee and lower leg

0.93

0.03

1.1

1.2

—

Dorsopathies

1.09

0.03

1.0

1.2

—

Other bacterial diseases

0.93

0.02

1.1

1.2

—

Asthma, including avohilmo

1.04

0.00

1.1

1.2

—

Asthma (diagnoses ohter than nonallergic)

1.05

0.00

1.1

—

Benign neoplasms

1.05

0.00

1.1

—

Falls/tendency to fall

0.99

0.00

1.1

1.2

—

Arthropathies

1.01

0.00

1.2

—

Autoimmune diseases

0.99

0.00

1.1

1.2

—

Other joint disorders

0.99

0.00

1.1

1.2

—

Mandibular prognathia

0.00

0.0

1.1

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

0.0

1.2

—

Other and unspecified injuries of lower leg

0.00

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.0

1.0

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.2

—

Congenital malformations of spine and bony thorax, including avohilmo

0.00

0.0

1.2

—

Crohn disease (strict definition, require KELA)

0.00

0.0

1.0

—

Malignant neoplasm of breast, including Hilmo

0.00

0.0

1.0

—

Single delivery by caesarean section

0.00

0.0

1.2

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.0

1.1

—

Maxillary retrognathism

0.00

0.0

1.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

0.99

0.00

1.0

1.3

—

Psoriasis vulgaris

0.00

0.0

1.0

—

Disorders of continuity of bone

0.00

0.0

1.0

—

Other osteochondrodysplasias, including avohilmo

0.00

0.0

1.2

—

Exclusion endpoint for supernumerary teeth

0.00

-0.00

0.0

1.1

—

Torsion of testis

0.00

-0.00

0.0

1.2

—

Seronegative juvenile rheumatoid arthritis

0.00

-0.00

0.0

1.1

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

-0.00

0.0

1.0

—

Polycystic kidney disease

0.00

-0.00

0.0

1.2

—

Other enthesopathies

0.00

-0.00

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

0.00

-0.00

0.0

1.2

—

Acute alcohol intoxication, ICD10

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of head

0.00

-0.00

0.0

1.1

—

Aortic hypoplasia

0.00

-0.00

0.0

1.1

—

Percutaneous Coronary Intervention

0.95

-0.00

1.0

1.2

—

Cleft lip, lip and palate or palate

0.00

-0.00

0.0

1.0

—

Lower back pain or/and sciatica

0.86

-0.00

1.0

1.1

—

Impacted maxillary canine

0.00

-0.00

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

0.00

-0.00

0.0

1.1

—

Pectus excavatum, including avohilmo

0.00

-0.00

0.0

1.0

—

Dorsalgia

0.98

-0.00

1.0

1.2

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

1.2

—

Maternal care for known or suspected fetal abnormality and damage

0.00

-0.00

0.0

1.2

—

Retinal detachments and breaks

0.00

-0.00

0.0

1.0

—

Idiopathic thrombocytopenic purpura

0.00

-0.00

0.0

1.2

—

Contact with other hot metals

0.00

-0.00

0.0

1.0

—

Diabetic retinopathy, strict definition

0.00

-0.00

0.0

1.1

—

Other adrenocortical overactivity

0.00

-0.00

0.0

1.0

—

Fall involving bed

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system, including avohilmo

0.90

-0.00

1.0

1.2

—

Urinary track infection

1.00

-0.00

1.5

1.1

—

Prolonged pregnancy

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of digestive organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Gonarthrosis

0.00

-0.00

0.0

1.0

—

Alcohol abuse, main dg

0.00

-0.00

0.0

1.0

—

Deep bite

0.89

-0.00

1.3

1.2

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

-0.00

0.0

1.0

—

Scarlet fever, including avohilmo

0.00

-0.00

0.0

1.1

—

Other diseases of hard tissues of teeth

0.95

-0.00

1.1

1.2

—

Contact with other sharp object(s)

0.00

-0.00

0.0

1.0

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

1.0

—

Haemangioma, any site

0.00

-0.00

0.0

1.7

—

Herpesviral [herpes simplex] infections

0.00

-0.00

0.0

1.2

—

Disorders of vitreous body

0.00

-0.00

0.0

1.0

—

Ingrowing nail

0.00

-0.00

0.0

1.0

—

Other otitis externa (chronic)

0.00

-0.00

0.0

1.2

—

Unspecified kidney failure

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected malpresentation of fetus

0.00

-0.00

0.0

1.2

—

Other complications of labour and delivery, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Other congenital malformations of ear

0.00

-0.00

0.0

1.2

—

Pediculosis, acariasis and other infestations

0.00

-0.00

0.0

1.2

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

-0.00

0.0

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

Other disorders of optic disc

0.00

-0.00

0.0

1.2

—

Pneumococcal septicemia

0.00

-0.00

0.0

1.1

—

Other and unspecified iridocyclitis

0.00

-0.00

0.0

1.0

—

Other sleep disorders

0.00

-0.00

0.0

1.0

—

Other congenital malformations of intestine, including avohilmo

0.00

-0.00

0.0

1.0

—

Pollen allergy

0.96

-0.00

1.0

1.2

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of digestive organs

0.00

-0.00

0.0

1.0

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

1.1

—

Renal agenesis and other reduction defects of kidney, including avohilmo

0.00

-0.00

0.0

1.2

—

Dental operations

0.92

-0.00

1.0

1.2

—

Other osteochondrodysplasias

0.00

-0.00

0.0

1.2

—

Acute alcohol intoxication

0.00

-0.00

0.0

1.0

—

Emergency coronary revascularization (for ACS)

0.93

-0.00

1.0

1.2

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

1.0

—

Other congenital malformations of intestine

0.00

-0.00

0.0

1.0

—

D07AA Corticosteroids, weak (group I)

0.98

-0.00

1.2

—

Nasal polyp

0.00

-0.00

0.0

1.0

—

Underdevelopment of the second kidney

0.00

-0.00

0.0

1.2

—

Lactose intolerance

0.00

-0.00

0.0

1.0

—

Neonatal jaundice from other and unspecified causes

0.88

-0.00

1.4

1.2

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.2

—

Other and unspecified disorders of vitreous body

0.00

-0.00

0.0

1.0

—

Pneumonia due to Streptococcus pneumoniae

0.00

-0.00

0.0

1.2

—

Chalazion

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm

0.00

-0.00

0.0

1.0

—

Glaucoma

0.00

-0.00

0.0

1.0

—

Renal agenesis and other reduction defects of kidney

0.00

-0.00

0.0

1.2

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.1

—

Haemangioma and lymphangioma, any site

0.00

-0.00

0.0

1.6

—

Haemorrhagic and haematological disorders of fetus and newborn

0.99

-0.00

1.3

1.2

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.0

—

Mesial bite

0.00

-0.00

0.0

1.0

—

Other congenital malformations of kidney

0.00

-0.00

0.0

1.2

—

Birth trauma

0.00

-0.00

0.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.90

-0.00

1.1

1.2

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.00

-0.00

0.0

1.1

—

Pneumonia derived septicemia

0.00

-0.00

0.0

1.5

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

1.0

—

Coronary revascularization (ANGIO or CABG)

0.95

-0.00

1.0

1.2

—

Café au lait spots

0.00

-0.00

0.0

1.8

—

Diseases of oral cavity, salivary glands and jaws

0.92

-0.00

1.1

1.2

—

Propionic acid derivatives

1.01

-0.00

1.2

1.0

—

Foreign body on external eye

0.00

-0.00

0.0

1.2

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.0

—

Operations 1 for CAVS

0.00

-0.00

0.0

1.2

—

0.98

-0.00

1.3

1.2

—

Malignant neoplasm of breast, HER2-negative

0.00

-0.00

0.0

1.0

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of breast

0.00

-0.00

0.0

1.0

—

Osteomyelitis

0.00

-0.00

0.0

1.0

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

-0.00

0.0

1.0

—

Insulin medication

0.90

-0.00

1.0

1.3

—

Scabies

0.00

-0.00

0.0

1.2

—

Scarlet fever

0.00

-0.00

0.0

1.2

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

-0.00

0.0

1.1

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Organic acids panel - Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS